CLINICAL PHARMACOKINETICS OF NITRAZEPAM

被引：38

作者：

KANGAS, L

BREIMER, DD

机构：

[1] UNIV TURKU,DEPT PHARMACOL,SF-20500 TURKU 50,FINLAND

[2] STATE UNIV LEIDEN,SUBFAC PHARM,DEPT PHARMACOL,LEIDEN,NETHERLANDS

来源：

CLINICAL PHARMACOKINETICS | 1981年 / 6卷 / 05期

关键词：

D O I：

10.2165/00003088-198106050-00002

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

页码：346 / 366

页数：21

共 106 条

[1]

ADAM K, 1976, Postgraduate Medical Journal, V52, P42

[2] NITRAZEPAM - LASTINGLY EFFECTIVE BUT TROUBLE ON WITHDRAWAL [J].

ADAM, K ;

ADAMSON, L ;

BREZINOVA, V ;

HUNTER, WM ;

OSWALD, I .

BRITISH MEDICAL JOURNAL, 1976, 1 (6025) :1558-1560

[3] PRE-SLEEP INGESTION OF 2 HYPNOTIC DRUGS AND SUBSEQUENT PERFORMANCE [J].

ADAMS, RG .

PSYCHOPHARMACOLOGIA, 1974, 40 (02) :185-190

[4]

Amrein R, 1979, SLEEP RES, P83

[5] NITRAZEPAM (MOGADON) AS A SLEEP-INDUCING AGENT [J].

ANDERSEN, T ;

LINGJAERDE, O .

BRITISH JOURNAL OF PSYCHIATRY, 1969, 115 (529) :1393-+

[6] EFFECTS OF HYPNOTICS ON IMIPRAMINE TREATMENT [J].

BALLINGER, BR ;

PRESLY, A ;

REID, AH ;

STEVENSON, IH .

PSYCHOPHARMACOLOGIA, 1974, 39 (03) :267-274

[7]

BEHARREL GP, 1973, J CHROMATOGR, V70, P45

[8] BENZODIAZEPINES - CLINICAL-PHARMACOLOGY AND THERAPEUTIC USE [J].

BELLANTUONO, C ;

REGGI, V ;

TOGNONI, G ;

GARATTINI, S .

DRUGS, 1980, 19 (03) :195-219

[9]

BEYER KH, 1969, ARZNEI-FORSCHUNG, V19, P1929

[10] RESIDUAL EFFECTS OF HYPNOTICS [J].

BOND, AJ ;

LADER, MH .

PSYCHOPHARMACOLOGIA, 1972, 25 (02) :117-+

← 1 2 3 4 5 6 7 8 9 10 →